nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCC2—epilepsy syndrome	0.0603	0.289	CbGaD
Tamoxifen—ABCG2—epilepsy syndrome	0.0533	0.255	CbGaD
Tamoxifen—CYP2C19—epilepsy syndrome	0.0419	0.201	CbGaD
Tamoxifen—UGT1A4—Lamotrigine—epilepsy syndrome	0.0315	0.0813	CbGbCtD
Tamoxifen—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0312	0.144	CrCrCtD
Tamoxifen—CYP2D6—epilepsy syndrome	0.0311	0.149	CbGaD
Tamoxifen—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0279	0.129	CrCrCtD
Tamoxifen—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0243	0.112	CrCrCtD
Tamoxifen—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0223	0.103	CrCrCtD
Tamoxifen—ABCB1—epilepsy syndrome	0.0222	0.106	CbGaD
Tamoxifen—UGT1A4—Midazolam—epilepsy syndrome	0.0214	0.0552	CbGbCtD
Tamoxifen—Benzphetamine—Phenytoin—epilepsy syndrome	0.0207	0.0954	CrCrCtD
Tamoxifen—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0191	0.0884	CrCrCtD
Tamoxifen—CES1—Rufinamide—epilepsy syndrome	0.0185	0.0477	CbGbCtD
Tamoxifen—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0183	0.0847	CrCrCtD
Tamoxifen—Promazine—Carbamazepine—epilepsy syndrome	0.0182	0.084	CrCrCtD
Tamoxifen—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0177	0.0816	CrCrCtD
Tamoxifen—Promazine—Oxcarbazepine—epilepsy syndrome	0.0168	0.0774	CrCrCtD
Tamoxifen—UGT1A4—Valproic Acid—epilepsy syndrome	0.0162	0.0418	CbGbCtD
Tamoxifen—ABCC2—Levetiracetam—epilepsy syndrome	0.00948	0.0245	CbGbCtD
Tamoxifen—CYP1B1—Propofol—epilepsy syndrome	0.00866	0.0223	CbGbCtD
Tamoxifen—CYP1B1—Phenobarbital—epilepsy syndrome	0.00827	0.0214	CbGbCtD
Tamoxifen—ABCB11—Phenobarbital—epilepsy syndrome	0.00827	0.0214	CbGbCtD
Tamoxifen—CYP2A6—Amobarbital—epilepsy syndrome	0.00596	0.0154	CbGbCtD
Tamoxifen—ABCC2—Carbamazepine—epilepsy syndrome	0.00544	0.014	CbGbCtD
Tamoxifen—CYP2E1—Trimethadione—epilepsy syndrome	0.00519	0.0134	CbGbCtD
Tamoxifen—CYP2E1—Felbamate—epilepsy syndrome	0.00519	0.0134	CbGbCtD
Tamoxifen—ABCC2—Phenytoin—epilepsy syndrome	0.00488	0.0126	CbGbCtD
Tamoxifen—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00482	0.0124	CbGbCtD
Tamoxifen—CYP2A6—Propofol—epilepsy syndrome	0.00445	0.0115	CbGbCtD
Tamoxifen—CYP2E1—Clonazepam—epilepsy syndrome	0.00442	0.0114	CbGbCtD
Tamoxifen—ABCC2—Phenobarbital—epilepsy syndrome	0.00435	0.0112	CbGbCtD
Tamoxifen—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00434	0.0112	CbGbCtD
Tamoxifen—CYP2A6—Phenobarbital—epilepsy syndrome	0.00425	0.011	CbGbCtD
Tamoxifen—CYP2B6—Clobazam—epilepsy syndrome	0.00418	0.0108	CbGbCtD
Tamoxifen—CYP2C8—Trimethadione—epilepsy syndrome	0.00388	0.01	CbGbCtD
Tamoxifen—CYP1A1—Propofol—epilepsy syndrome	0.0038	0.0098	CbGbCtD
Tamoxifen—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00365	0.00941	CbGbCtD
Tamoxifen—CYP3A7—Carbamazepine—epilepsy syndrome	0.00363	0.00938	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00363	0.00938	CbGbCtD
Tamoxifen—CYP1A1—Phenobarbital—epilepsy syndrome	0.00363	0.00937	CbGbCtD
Tamoxifen—CYP2E1—Rufinamide—epilepsy syndrome	0.0036	0.00929	CbGbCtD
Tamoxifen—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0035	0.00904	CbGbCtD
Tamoxifen—CYP2B6—Carbamazepine—epilepsy syndrome	0.00346	0.00893	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00326	0.00841	CbGbCtD
Tamoxifen—CYP3A7—Phenytoin—epilepsy syndrome	0.00326	0.00841	CbGbCtD
Tamoxifen—CYP2C19—Felbamate—epilepsy syndrome	0.00326	0.0084	CbGbCtD
Tamoxifen—CYP2C19—Trimethadione—epilepsy syndrome	0.00326	0.0084	CbGbCtD
Tamoxifen—CYP2B6—Primidone—epilepsy syndrome	0.00323	0.00834	CbGbCtD
Tamoxifen—CYP2A6—Valproic Acid—epilepsy syndrome	0.00318	0.0082	CbGbCtD
Tamoxifen—CYP2B6—Phenytoin—epilepsy syndrome	0.0031	0.00801	CbGbCtD
Tamoxifen—ABCB1—Levetiracetam—epilepsy syndrome	0.00309	0.00797	CbGbCtD
Tamoxifen—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00306	0.0079	CbGbCtD
Tamoxifen—CYP2E1—Propofol—epilepsy syndrome	0.00293	0.00757	CbGbCtD
Tamoxifen—CYP3A7—Phenobarbital—epilepsy syndrome	0.00291	0.0075	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00291	0.0075	CbGbCtD
Tamoxifen—CYP2B6—Propofol—epilepsy syndrome	0.00289	0.00747	CbGbCtD
Tamoxifen—CYP3A7—Midazolam—epilepsy syndrome	0.00286	0.00739	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00286	0.00739	CbGbCtD
Tamoxifen—CYP2E1—Phenobarbital—epilepsy syndrome	0.0028	0.00724	CbGbCtD
Tamoxifen—CYP2B6—Phenobarbital—epilepsy syndrome	0.00277	0.00714	CbGbCtD
Tamoxifen—CYP2E1—Midazolam—epilepsy syndrome	0.00277	0.00714	CbGbCtD
Tamoxifen—CYP3A7—Diazepam—epilepsy syndrome	0.00275	0.00711	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00275	0.00711	CbGbCtD
Tamoxifen—CYP2B6—Midazolam—epilepsy syndrome	0.00273	0.00704	CbGbCtD
Tamoxifen—CYP3A5—Carbamazepine—epilepsy syndrome	0.00273	0.00703	CbGbCtD
Tamoxifen—CYP2C9—Trimethadione—epilepsy syndrome	0.00271	0.00698	CbGbCtD
Tamoxifen—CYP2E1—Diazepam—epilepsy syndrome	0.00266	0.00686	CbGbCtD
Tamoxifen—CYP2C19—Clobazam—epilepsy syndrome	0.00265	0.00685	CbGbCtD
Tamoxifen—CYP2B6—Diazepam—epilepsy syndrome	0.00262	0.00677	CbGbCtD
Tamoxifen—CYP2C8—Carbamazepine—epilepsy syndrome	0.00262	0.00676	CbGbCtD
Tamoxifen—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00254	0.00657	CbGbCtD
Tamoxifen—CYP2C8—Primidone—epilepsy syndrome	0.00245	0.00631	CbGbCtD
Tamoxifen—CYP3A5—Phenytoin—epilepsy syndrome	0.00245	0.00631	CbGbCtD
Tamoxifen—CYP2C8—Phenytoin—epilepsy syndrome	0.00235	0.00607	CbGbCtD
Tamoxifen—CYP2C19—Carbamazepine—epilepsy syndrome	0.0022	0.00567	CbGbCtD
Tamoxifen—CYP2C8—Propofol—epilepsy syndrome	0.00219	0.00566	CbGbCtD
Tamoxifen—CYP3A5—Phenobarbital—epilepsy syndrome	0.00218	0.00562	CbGbCtD
Tamoxifen—CYP3A5—Midazolam—epilepsy syndrome	0.00215	0.00555	CbGbCtD
Tamoxifen—ABCB1—Clobazam—epilepsy syndrome	0.00214	0.00553	CbGbCtD
Tamoxifen—CYP2C8—Phenobarbital—epilepsy syndrome	0.0021	0.00541	CbGbCtD
Tamoxifen—CYP2B6—Valproic Acid—epilepsy syndrome	0.00207	0.00533	CbGbCtD
Tamoxifen—CYP3A5—Diazepam—epilepsy syndrome	0.00207	0.00533	CbGbCtD
Tamoxifen—ABCB1—Lamotrigine—epilepsy syndrome	0.00206	0.00532	CbGbCtD
Tamoxifen—CYP2C19—Primidone—epilepsy syndrome	0.00205	0.0053	CbGbCtD
Tamoxifen—CYP1A2—Carbamazepine—epilepsy syndrome	0.00203	0.00524	CbGbCtD
Tamoxifen—CYP2C8—Diazepam—epilepsy syndrome	0.00199	0.00513	CbGbCtD
Tamoxifen—CYP2C19—Phenytoin—epilepsy syndrome	0.00197	0.00509	CbGbCtD
Tamoxifen—CYP1A2—Primidone—epilepsy syndrome	0.00189	0.00489	CbGbCtD
Tamoxifen—CYP2C19—Propofol—epilepsy syndrome	0.00184	0.00475	CbGbCtD
Tamoxifen—CYP2C9—Carbamazepine—epilepsy syndrome	0.00183	0.00472	CbGbCtD
Tamoxifen—ABCB1—Carbamazepine—epilepsy syndrome	0.00177	0.00458	CbGbCtD
Tamoxifen—CYP2C19—Phenobarbital—epilepsy syndrome	0.00176	0.00454	CbGbCtD
Tamoxifen—CYP2C9—Primidone—epilepsy syndrome	0.00171	0.0044	CbGbCtD
Tamoxifen—CYP1A2—Propofol—epilepsy syndrome	0.0017	0.00438	CbGbCtD
Tamoxifen—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00169	0.00437	CbGbCtD
Tamoxifen—CYP2C19—Diazepam—epilepsy syndrome	0.00167	0.0043	CbGbCtD
Tamoxifen—CYP2C9—Phenytoin—epilepsy syndrome	0.00164	0.00423	CbGbCtD
Tamoxifen—CYP3A5—Valproic Acid—epilepsy syndrome	0.00163	0.0042	CbGbCtD
Tamoxifen—CYP2C19—Zonisamide—epilepsy syndrome	0.00163	0.0042	CbGbCtD
Tamoxifen—CYP1A2—Phenobarbital—epilepsy syndrome	0.00162	0.00419	CbGbCtD
Tamoxifen—ABCB1—Phenytoin—epilepsy syndrome	0.00159	0.00411	CbGbCtD
Tamoxifen—CYP3A4—Felbamate—epilepsy syndrome	0.00157	0.00406	CbGbCtD
Tamoxifen—CYP3A4—Trimethadione—epilepsy syndrome	0.00157	0.00406	CbGbCtD
Tamoxifen—CYP2C8—Valproic Acid—epilepsy syndrome	0.00157	0.00404	CbGbCtD
Tamoxifen—CYP1A2—Diazepam—epilepsy syndrome	0.00154	0.00397	CbGbCtD
Tamoxifen—CYP2C9—Propofol—epilepsy syndrome	0.00153	0.00395	CbGbCtD
Tamoxifen—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00148	0.00382	CbGbCtD
Tamoxifen—CYP2C9—Phenobarbital—epilepsy syndrome	0.00146	0.00377	CbGbCtD
Tamoxifen—ABCB1—Phenobarbital—epilepsy syndrome	0.00142	0.00366	CbGbCtD
Tamoxifen—ABCB1—Midazolam—epilepsy syndrome	0.0014	0.00361	CbGbCtD
Tamoxifen—CYP2D6—Propofol—epilepsy syndrome	0.0014	0.00361	CbGbCtD
Tamoxifen—CYP2C9—Diazepam—epilepsy syndrome	0.00139	0.00358	CbGbCtD
Tamoxifen—ABCB1—Diazepam—epilepsy syndrome	0.00134	0.00347	CbGbCtD
Tamoxifen—CYP3A4—Clonazepam—epilepsy syndrome	0.00134	0.00345	CbGbCtD
Tamoxifen—CYP2C19—Valproic Acid—epilepsy syndrome	0.00131	0.00339	CbGbCtD
Tamoxifen—CYP3A4—Clobazam—epilepsy syndrome	0.00128	0.00331	CbGbCtD
Tamoxifen—CYP1A2—Valproic Acid—epilepsy syndrome	0.00121	0.00313	CbGbCtD
Tamoxifen—CYP2C19—Topiramate—epilepsy syndrome	0.00119	0.00306	CbGbCtD
Tamoxifen—CYP2C9—Valproic Acid—epilepsy syndrome	0.00109	0.00282	CbGbCtD
Tamoxifen—CYP3A4—Rufinamide—epilepsy syndrome	0.00109	0.00281	CbGbCtD
Tamoxifen—CYP3A4—Carbamazepine—epilepsy syndrome	0.00106	0.00274	CbGbCtD
Tamoxifen—CYP3A4—Primidone—epilepsy syndrome	0.000992	0.00256	CbGbCtD
Tamoxifen—CYP3A4—Phenytoin—epilepsy syndrome	0.000953	0.00246	CbGbCtD
Tamoxifen—CYP3A4—Propofol—epilepsy syndrome	0.000889	0.00229	CbGbCtD
Tamoxifen—CYP3A4—Acetazolamide—epilepsy syndrome	0.00085	0.00219	CbGbCtD
Tamoxifen—CYP3A4—Phenobarbital—epilepsy syndrome	0.00085	0.00219	CbGbCtD
Tamoxifen—CYP3A4—Midazolam—epilepsy syndrome	0.000838	0.00216	CbGbCtD
Tamoxifen—CYP3A4—Diazepam—epilepsy syndrome	0.000806	0.00208	CbGbCtD
Tamoxifen—CYP3A4—Zonisamide—epilepsy syndrome	0.000786	0.00203	CbGbCtD
Tamoxifen—SULT1A1—forebrain—epilepsy syndrome	0.000659	0.029	CbGeAlD
Tamoxifen—CYP3A4—Valproic Acid—epilepsy syndrome	0.000635	0.00164	CbGbCtD
Tamoxifen—SULT1A1—telencephalon—epilepsy syndrome	0.000606	0.0267	CbGeAlD
Tamoxifen—CYP3A4—Topiramate—epilepsy syndrome	0.000573	0.00148	CbGbCtD
Tamoxifen—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.000518	1	CbGdCrCtD
Tamoxifen—ESR2—hindbrain—epilepsy syndrome	0.000501	0.022	CbGeAlD
Tamoxifen—EBPL—head—epilepsy syndrome	0.000475	0.0209	CbGeAlD
Tamoxifen—FMO1—forebrain—epilepsy syndrome	0.000469	0.0206	CbGeAlD
Tamoxifen—DHCR7—forebrain—epilepsy syndrome	0.000469	0.0206	CbGeAlD
Tamoxifen—EBPL—nervous system—epilepsy syndrome	0.00045	0.0198	CbGeAlD
Tamoxifen—EBPL—central nervous system—epilepsy syndrome	0.000433	0.0191	CbGeAlD
Tamoxifen—DHCR7—telencephalon—epilepsy syndrome	0.000431	0.019	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—epilepsy syndrome	0.000424	0.0187	CbGeAlD
Tamoxifen—EBPL—cerebellum—epilepsy syndrome	0.000424	0.0187	CbGeAlD
Tamoxifen—SULT1A1—head—epilepsy syndrome	0.000377	0.0166	CbGeAlD
Tamoxifen—SULT1A1—nervous system—epilepsy syndrome	0.000358	0.0157	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—epilepsy syndrome	0.000344	0.0152	CbGeAlD
Tamoxifen—EBPL—brain—epilepsy syndrome	0.000344	0.0152	CbGeAlD
Tamoxifen—ESR1—hindbrain—epilepsy syndrome	0.000343	0.0151	CbGeAlD
Tamoxifen—DHCR7—medulla oblongata—epilepsy syndrome	0.000339	0.0149	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—epilepsy syndrome	0.000337	0.0148	CbGeAlD
Tamoxifen—ESRRA—medulla oblongata—epilepsy syndrome	0.000333	0.0147	CbGeAlD
Tamoxifen—DHCR7—midbrain—epilepsy syndrome	0.000309	0.0136	CbGeAlD
Tamoxifen—ESRRA—midbrain—epilepsy syndrome	0.000305	0.0134	CbGeAlD
Tamoxifen—DHCR7—spinal cord—epilepsy syndrome	0.000302	0.0133	CbGeAlD
Tamoxifen—ESRRA—spinal cord—epilepsy syndrome	0.000297	0.0131	CbGeAlD
Tamoxifen—ESR2—brainstem—epilepsy syndrome	0.000287	0.0126	CbGeAlD
Tamoxifen—ESR2—forebrain—epilepsy syndrome	0.000277	0.0122	CbGeAlD
Tamoxifen—SULT1A1—brain—epilepsy syndrome	0.000273	0.012	CbGeAlD
Tamoxifen—DHCR7—head—epilepsy syndrome	0.000268	0.0118	CbGeAlD
Tamoxifen—FMO1—head—epilepsy syndrome	0.000268	0.0118	CbGeAlD
Tamoxifen—ESRRA—head—epilepsy syndrome	0.000264	0.0116	CbGeAlD
Tamoxifen—ESR2—telencephalon—epilepsy syndrome	0.000255	0.0112	CbGeAlD
Tamoxifen—DHCR7—nervous system—epilepsy syndrome	0.000254	0.0112	CbGeAlD
Tamoxifen—FMO1—nervous system—epilepsy syndrome	0.000254	0.0112	CbGeAlD
Tamoxifen—ESRRA—nervous system—epilepsy syndrome	0.00025	0.011	CbGeAlD
Tamoxifen—DHCR7—central nervous system—epilepsy syndrome	0.000245	0.0108	CbGeAlD
Tamoxifen—FMO1—central nervous system—epilepsy syndrome	0.000245	0.0108	CbGeAlD
Tamoxifen—ESRRA—central nervous system—epilepsy syndrome	0.000241	0.0106	CbGeAlD
Tamoxifen—DHCR7—cerebellum—epilepsy syndrome	0.000239	0.0105	CbGeAlD
Tamoxifen—ESRRA—cerebellum—epilepsy syndrome	0.000236	0.0104	CbGeAlD
Tamoxifen—FMO3—head—epilepsy syndrome	0.000232	0.0102	CbGeAlD
Tamoxifen—FMO3—nervous system—epilepsy syndrome	0.00022	0.00968	CbGeAlD
Tamoxifen—CYP19A1—forebrain—epilepsy syndrome	0.000218	0.00961	CbGeAlD
Tamoxifen—Diphemanil Methylsulfate—CHRM3—epilepsy syndrome	0.000212	0.0841	CrCbGaD
Tamoxifen—FMO3—central nervous system—epilepsy syndrome	0.000212	0.00932	CbGeAlD
Tamoxifen—Diphemanil Methylsulfate—CHRM1—epilepsy syndrome	0.000198	0.0784	CrCbGaD
Tamoxifen—SIGMAR1—telencephalon—epilepsy syndrome	0.000197	0.00868	CbGeAlD
Tamoxifen—ESR1—brainstem—epilepsy syndrome	0.000196	0.00865	CbGeAlD
Tamoxifen—FMO1—brain—epilepsy syndrome	0.000194	0.00856	CbGeAlD
Tamoxifen—DHCR7—brain—epilepsy syndrome	0.000194	0.00856	CbGeAlD
Tamoxifen—ESRRA—brain—epilepsy syndrome	0.000191	0.00843	CbGeAlD
Tamoxifen—ESR1—forebrain—epilepsy syndrome	0.00019	0.00835	CbGeAlD
Tamoxifen—CYP2D6—hindbrain—epilepsy syndrome	0.000188	0.00829	CbGeAlD
Tamoxifen—CYP1B1—telencephalon—epilepsy syndrome	0.000188	0.00826	CbGeAlD
Tamoxifen—CES1—head—epilepsy syndrome	0.000183	0.00806	CbGeAlD
Tamoxifen—Loperamide—CACNA1A—epilepsy syndrome	0.000182	0.072	CrCbGaD
Tamoxifen—ESR1—telencephalon—epilepsy syndrome	0.000174	0.00768	CbGeAlD
Tamoxifen—CES1—nervous system—epilepsy syndrome	0.000174	0.00764	CbGeAlD
Tamoxifen—FMO3—brain—epilepsy syndrome	0.000168	0.0074	CbGeAlD
Tamoxifen—CES1—central nervous system—epilepsy syndrome	0.000167	0.00736	CbGeAlD
Tamoxifen—ESR2—head—epilepsy syndrome	0.000159	0.00698	CbGeAlD
Tamoxifen—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000155	0.00682	CbGeAlD
Tamoxifen—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000151	0.06	CrCbGaD
Tamoxifen—ESR2—nervous system—epilepsy syndrome	0.00015	0.00662	CbGeAlD
Tamoxifen—ESR2—central nervous system—epilepsy syndrome	0.000145	0.00637	CbGeAlD
Tamoxifen—CYP2A6—cerebellum—epilepsy syndrome	0.000142	0.00626	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—epilepsy syndrome	0.000142	0.00624	CbGeAlD
Tamoxifen—ESR2—cerebellum—epilepsy syndrome	0.000141	0.00623	CbGeAlD
Tamoxifen—ABCG2—telencephalon—epilepsy syndrome	0.00014	0.00615	CbGeAlD
Tamoxifen—SIGMAR1—spinal cord—epilepsy syndrome	0.000138	0.00608	CbGeAlD
Tamoxifen—CES1—brain—epilepsy syndrome	0.000133	0.00584	CbGeAlD
Tamoxifen—Loperamide—POMC—epilepsy syndrome	0.000126	0.0499	CrCbGaD
Tamoxifen—CYP19A1—head—epilepsy syndrome	0.000125	0.0055	CbGeAlD
Tamoxifen—CYP2E1—telencephalon—epilepsy syndrome	0.000121	0.00532	CbGeAlD
Tamoxifen—CYP19A1—nervous system—epilepsy syndrome	0.000118	0.00521	CbGeAlD
Tamoxifen—CYP1B1—head—epilepsy syndrome	0.000117	0.00514	CbGeAlD
Tamoxifen—CYP2A6—brain—epilepsy syndrome	0.000115	0.00508	CbGeAlD
Tamoxifen—Clomifene—CYP11A1—epilepsy syndrome	0.000115	0.0457	CrCbGaD
Tamoxifen—ESR2—brain—epilepsy syndrome	0.000115	0.00506	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—epilepsy syndrome	0.000114	0.00502	CbGeAlD
Tamoxifen—CYP1B1—nervous system—epilepsy syndrome	0.000111	0.00487	CbGeAlD
Tamoxifen—Doxylamine—CHRM1—epilepsy syndrome	0.000111	0.0438	CrCbGaD
Tamoxifen—ABCG2—medulla oblongata—epilepsy syndrome	0.00011	0.00483	CbGeAlD
Tamoxifen—SIGMAR1—cerebellum—epilepsy syndrome	0.00011	0.00482	CbGeAlD
Tamoxifen—ESR1—head—epilepsy syndrome	0.000109	0.00478	CbGeAlD
Tamoxifen—CYP2D6—brainstem—epilepsy syndrome	0.000108	0.00475	CbGeAlD
Tamoxifen—CYP1B1—central nervous system—epilepsy syndrome	0.000107	0.00469	CbGeAlD
Tamoxifen—CYP1B1—cerebellum—epilepsy syndrome	0.000104	0.00459	CbGeAlD
Tamoxifen—CYP2D6—forebrain—epilepsy syndrome	0.000104	0.00458	CbGeAlD
Tamoxifen—ESR1—nervous system—epilepsy syndrome	0.000103	0.00453	CbGeAlD
Tamoxifen—ABCG2—midbrain—epilepsy syndrome	0.0001	0.00442	CbGeAlD
Tamoxifen—ESR1—central nervous system—epilepsy syndrome	9.91e-05	0.00436	CbGeAlD
Tamoxifen—ABCG2—spinal cord—epilepsy syndrome	9.79e-05	0.00431	CbGeAlD
Tamoxifen—ESR1—cerebellum—epilepsy syndrome	9.69e-05	0.00426	CbGeAlD
Tamoxifen—CYP2D6—telencephalon—epilepsy syndrome	9.57e-05	0.00422	CbGeAlD
Tamoxifen—CYP2E1—medulla oblongata—epilepsy syndrome	9.5e-05	0.00418	CbGeAlD
Tamoxifen—Orphenadrine—SCN9A—epilepsy syndrome	9.37e-05	0.0372	CrCbGaD
Tamoxifen—CYP19A1—brain—epilepsy syndrome	9.05e-05	0.00399	CbGeAlD
Tamoxifen—SIGMAR1—brain—epilepsy syndrome	8.9e-05	0.00392	CbGeAlD
Tamoxifen—Orphenadrine—SCN4A—epilepsy syndrome	8.61e-05	0.0341	CrCbGaD
Tamoxifen—CYP2E1—spinal cord—epilepsy syndrome	8.47e-05	0.00373	CbGeAlD
Tamoxifen—CYP1B1—brain—epilepsy syndrome	8.46e-05	0.00373	CbGeAlD
Tamoxifen—CYP1A1—head—epilepsy syndrome	8.26e-05	0.00363	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCG2—epilepsy syndrome	8.17e-05	0.0324	CrCbGaD
Tamoxifen—CYP2B6—head—epilepsy syndrome	8.02e-05	0.00353	CbGeAlD
Tamoxifen—ESR1—brain—epilepsy syndrome	7.87e-05	0.00346	CbGeAlD
Tamoxifen—CYP1A1—nervous system—epilepsy syndrome	7.83e-05	0.00345	CbGeAlD
Tamoxifen—ABCG2—cerebellum—epilepsy syndrome	7.76e-05	0.00342	CbGeAlD
Tamoxifen—CYP2B6—nervous system—epilepsy syndrome	7.61e-05	0.00335	CbGeAlD
Tamoxifen—CYP1A1—central nervous system—epilepsy syndrome	7.54e-05	0.00332	CbGeAlD
Tamoxifen—CYP2E1—head—epilepsy syndrome	7.53e-05	0.00331	CbGeAlD
Tamoxifen—ABCB1—forebrain—epilepsy syndrome	7.49e-05	0.0033	CbGeAlD
Tamoxifen—Dextropropoxyphene—OPRD1—epilepsy syndrome	7.44e-05	0.0295	CrCbGaD
Tamoxifen—CYP2B6—central nervous system—epilepsy syndrome	7.32e-05	0.00322	CbGeAlD
Tamoxifen—CYP2E1—nervous system—epilepsy syndrome	7.14e-05	0.00314	CbGeAlD
Tamoxifen—Loperamide—OPRD1—epilepsy syndrome	7.09e-05	0.0281	CrCbGaD
Tamoxifen—ABCB1—telencephalon—epilepsy syndrome	6.89e-05	0.00303	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—epilepsy syndrome	6.87e-05	0.00303	CbGeAlD
Tamoxifen—CYP2E1—cerebellum—epilepsy syndrome	6.72e-05	0.00296	CbGeAlD
Tamoxifen—Levomethadyl Acetate—OPRM1—epilepsy syndrome	6.59e-05	0.0261	CrCbGaD
Tamoxifen—CYP2C8—brain—epilepsy syndrome	6.48e-05	0.00285	CbGeAlD
Tamoxifen—ABCG2—brain—epilepsy syndrome	6.3e-05	0.00277	CbGeAlD
Tamoxifen—Orphenadrine—SCN1A—epilepsy syndrome	6.29e-05	0.0249	CrCbGaD
Tamoxifen—Ospemifene—CYP2C19—epilepsy syndrome	6.25e-05	0.0248	CrCbGaD
Tamoxifen—CYP1A1—brain—epilepsy syndrome	5.98e-05	0.00263	CbGeAlD
Tamoxifen—CYP2D6—head—epilepsy syndrome	5.96e-05	0.00262	CbGeAlD
Tamoxifen—CYP2B6—brain—epilepsy syndrome	5.81e-05	0.00256	CbGeAlD
Tamoxifen—CYP3A4—nervous system—epilepsy syndrome	5.74e-05	0.00253	CbGeAlD
Tamoxifen—Dextropropoxyphene—OPRM1—epilepsy syndrome	5.69e-05	0.0226	CrCbGaD
Tamoxifen—CYP2D6—nervous system—epilepsy syndrome	5.65e-05	0.00249	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—epilepsy syndrome	5.53e-05	0.00243	CbGeAlD
Tamoxifen—CYP2E1—brain—epilepsy syndrome	5.46e-05	0.0024	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—epilepsy syndrome	5.44e-05	0.0024	CbGeAlD
Tamoxifen—Loperamide—OPRM1—epilepsy syndrome	5.43e-05	0.0215	CrCbGaD
Tamoxifen—ABCB1—medulla oblongata—epilepsy syndrome	5.41e-05	0.00238	CbGeAlD
Tamoxifen—CYP2D6—cerebellum—epilepsy syndrome	5.32e-05	0.00234	CbGeAlD
Tamoxifen—Methadone—OPRD1—epilepsy syndrome	5.05e-05	0.02	CrCbGaD
Tamoxifen—ABCB1—midbrain—epilepsy syndrome	4.95e-05	0.00218	CbGeAlD
Tamoxifen—ABCB1—spinal cord—epilepsy syndrome	4.83e-05	0.00212	CbGeAlD
Tamoxifen—CYP2D6—brain—epilepsy syndrome	4.32e-05	0.0019	CbGeAlD
Tamoxifen—ABCB1—head—epilepsy syndrome	4.29e-05	0.00189	CbGeAlD
Tamoxifen—ABCB1—nervous system—epilepsy syndrome	4.07e-05	0.00179	CbGeAlD
Tamoxifen—Tripelennamine—CYP2D6—epilepsy syndrome	3.93e-05	0.0156	CrCbGaD
Tamoxifen—ABCB1—central nervous system—epilepsy syndrome	3.91e-05	0.00172	CbGeAlD
Tamoxifen—Methadone—OPRM1—epilepsy syndrome	3.86e-05	0.0153	CrCbGaD
Tamoxifen—Promazine—CHRM3—epilepsy syndrome	3.84e-05	0.0152	CrCbGaD
Tamoxifen—ABCB1—cerebellum—epilepsy syndrome	3.83e-05	0.00168	CbGeAlD
Tamoxifen—Benzphetamine—ADRA2A—epilepsy syndrome	3.61e-05	0.0143	CrCbGaD
Tamoxifen—Promazine—CHRM1—epilepsy syndrome	3.58e-05	0.0142	CrCbGaD
Tamoxifen—Cyclobenzaprine—HTR2A—epilepsy syndrome	3.57e-05	0.0142	CrCbGaD
Tamoxifen—Phenoxybenzamine—ADRA2A—epilepsy syndrome	3.45e-05	0.0137	CrCbGaD
Tamoxifen—Diethylstilbestrol—ABCB1—epilepsy syndrome	3.4e-05	0.0135	CrCbGaD
Tamoxifen—Diphenhydramine—CHRM2—epilepsy syndrome	3.39e-05	0.0134	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP2D6—epilepsy syndrome	3.26e-05	0.0129	CrCbGaD
Tamoxifen—Orphenadrine—CHRM2—epilepsy syndrome	3.2e-05	0.0127	CrCbGaD
Tamoxifen—ABCB1—brain—epilepsy syndrome	3.11e-05	0.00137	CbGeAlD
Tamoxifen—Promazine—CHRM2—epilepsy syndrome	2.92e-05	0.0116	CrCbGaD
Tamoxifen—Asthenia—Zonisamide—epilepsy syndrome	2.85e-05	0.000267	CcSEcCtD
Tamoxifen—Dry mouth—Valproic Acid—epilepsy syndrome	2.84e-05	0.000266	CcSEcCtD
Tamoxifen—Headache—Levetiracetam—epilepsy syndrome	2.83e-05	0.000266	CcSEcCtD
Tamoxifen—Erythema—Gabapentin—epilepsy syndrome	2.83e-05	0.000265	CcSEcCtD
Tamoxifen—Angioedema—Pregabalin—epilepsy syndrome	2.82e-05	0.000264	CcSEcCtD
Tamoxifen—Hypersensitivity—Clonazepam—epilepsy syndrome	2.82e-05	0.000264	CcSEcCtD
Tamoxifen—Dizziness—Vigabatrin—epilepsy syndrome	2.81e-05	0.000264	CcSEcCtD
Tamoxifen—Pruritus—Zonisamide—epilepsy syndrome	2.81e-05	0.000263	CcSEcCtD
Tamoxifen—Hypersensitivity—Phenytoin—epilepsy syndrome	2.8e-05	0.000262	CcSEcCtD
Tamoxifen—Oedema—Valproic Acid—epilepsy syndrome	2.78e-05	0.000261	CcSEcCtD
Tamoxifen—Urticaria—Lamotrigine—epilepsy syndrome	2.78e-05	0.000261	CcSEcCtD
Tamoxifen—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.78e-05	0.000261	CcSEcCtD
Tamoxifen—Nausea—Propofol—epilepsy syndrome	2.78e-05	0.000261	CcSEcCtD
Tamoxifen—Vomiting—Fosphenytoin—epilepsy syndrome	2.77e-05	0.00026	CcSEcCtD
Tamoxifen—Diarrhoea—Felbamate—epilepsy syndrome	2.77e-05	0.00026	CcSEcCtD
Tamoxifen—Abdominal pain—Lamotrigine—epilepsy syndrome	2.77e-05	0.00026	CcSEcCtD
Tamoxifen—Dysgeusia—Gabapentin—epilepsy syndrome	2.77e-05	0.00026	CcSEcCtD
Tamoxifen—Dizziness—Diazepam—epilepsy syndrome	2.77e-05	0.00026	CcSEcCtD
Tamoxifen—Infection—Valproic Acid—epilepsy syndrome	2.77e-05	0.000259	CcSEcCtD
Tamoxifen—Leukopenia—Pregabalin—epilepsy syndrome	2.76e-05	0.000259	CcSEcCtD
Tamoxifen—Rash—Fosphenytoin—epilepsy syndrome	2.75e-05	0.000258	CcSEcCtD
Tamoxifen—Dermatitis—Fosphenytoin—epilepsy syndrome	2.75e-05	0.000258	CcSEcCtD
Tamoxifen—Haemoglobin—Topiramate—epilepsy syndrome	2.75e-05	0.000258	CcSEcCtD
Tamoxifen—Asthenia—Clonazepam—epilepsy syndrome	2.74e-05	0.000257	CcSEcCtD
Tamoxifen—Back pain—Gabapentin—epilepsy syndrome	2.74e-05	0.000256	CcSEcCtD
Tamoxifen—Headache—Fosphenytoin—epilepsy syndrome	2.73e-05	0.000256	CcSEcCtD
Tamoxifen—Hepatitis—Topiramate—epilepsy syndrome	2.73e-05	0.000256	CcSEcCtD
Tamoxifen—Haemorrhage—Topiramate—epilepsy syndrome	2.73e-05	0.000256	CcSEcCtD
Tamoxifen—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.73e-05	0.000256	CcSEcCtD
Tamoxifen—Asthenia—Phenytoin—epilepsy syndrome	2.73e-05	0.000255	CcSEcCtD
Tamoxifen—Nausea—Midazolam—epilepsy syndrome	2.72e-05	0.000255	CcSEcCtD
Tamoxifen—Hypoaesthesia—Topiramate—epilepsy syndrome	2.72e-05	0.000255	CcSEcCtD
Tamoxifen—Muscle spasms—Gabapentin—epilepsy syndrome	2.72e-05	0.000255	CcSEcCtD
Tamoxifen—Diarrhoea—Zonisamide—epilepsy syndrome	2.71e-05	0.000255	CcSEcCtD
Tamoxifen—Pharyngitis—Topiramate—epilepsy syndrome	2.71e-05	0.000254	CcSEcCtD
Tamoxifen—Asthenia—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000254	CcSEcCtD
Tamoxifen—Pruritus—Clonazepam—epilepsy syndrome	2.71e-05	0.000254	CcSEcCtD
Tamoxifen—Vomiting—Vigabatrin—epilepsy syndrome	2.7e-05	0.000254	CcSEcCtD
Tamoxifen—Toremifene—ABCB1—epilepsy syndrome	2.7e-05	0.0107	CrCbGaD
Tamoxifen—Oedema peripheral—Topiramate—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Tamoxifen—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Tamoxifen—Cough—Pregabalin—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Tamoxifen—Pruritus—Phenytoin—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Tamoxifen—Nausea—Levetiracetam—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Tamoxifen—Rash—Vigabatrin—epilepsy syndrome	2.68e-05	0.000251	CcSEcCtD
Tamoxifen—Dizziness—Felbamate—epilepsy syndrome	2.68e-05	0.000251	CcSEcCtD
Tamoxifen—Dermatitis—Vigabatrin—epilepsy syndrome	2.68e-05	0.000251	CcSEcCtD
Tamoxifen—Pruritus—Oxcarbazepine—epilepsy syndrome	2.67e-05	0.000251	CcSEcCtD
Tamoxifen—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.67e-05	0.00025	CcSEcCtD
Tamoxifen—Headache—Vigabatrin—epilepsy syndrome	2.66e-05	0.00025	CcSEcCtD
Tamoxifen—Hypertension—Pregabalin—epilepsy syndrome	2.66e-05	0.00025	CcSEcCtD
Tamoxifen—Vomiting—Diazepam—epilepsy syndrome	2.66e-05	0.00025	CcSEcCtD
Tamoxifen—Anorexia—Valproic Acid—epilepsy syndrome	2.65e-05	0.000249	CcSEcCtD
Tamoxifen—Rash—Diazepam—epilepsy syndrome	2.64e-05	0.000248	CcSEcCtD
Tamoxifen—Dermatitis—Diazepam—epilepsy syndrome	2.64e-05	0.000247	CcSEcCtD
Tamoxifen—Visual impairment—Topiramate—epilepsy syndrome	2.63e-05	0.000247	CcSEcCtD
Tamoxifen—Myalgia—Pregabalin—epilepsy syndrome	2.63e-05	0.000246	CcSEcCtD
Tamoxifen—Arthralgia—Pregabalin—epilepsy syndrome	2.63e-05	0.000246	CcSEcCtD
Tamoxifen—Chest pain—Pregabalin—epilepsy syndrome	2.63e-05	0.000246	CcSEcCtD
Tamoxifen—Dizziness—Zonisamide—epilepsy syndrome	2.62e-05	0.000246	CcSEcCtD
Tamoxifen—Headache—Diazepam—epilepsy syndrome	2.62e-05	0.000246	CcSEcCtD
Tamoxifen—Anxiety—Pregabalin—epilepsy syndrome	2.62e-05	0.000245	CcSEcCtD
Tamoxifen—Diarrhoea—Clonazepam—epilepsy syndrome	2.62e-05	0.000245	CcSEcCtD
Tamoxifen—Anaemia—Gabapentin—epilepsy syndrome	2.61e-05	0.000245	CcSEcCtD
Tamoxifen—Asthenia—Carbamazepine—epilepsy syndrome	2.6e-05	0.000244	CcSEcCtD
Tamoxifen—Diarrhoea—Phenytoin—epilepsy syndrome	2.6e-05	0.000244	CcSEcCtD
Tamoxifen—Discomfort—Pregabalin—epilepsy syndrome	2.59e-05	0.000243	CcSEcCtD
Tamoxifen—Nausea—Fosphenytoin—epilepsy syndrome	2.59e-05	0.000243	CcSEcCtD
Tamoxifen—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.59e-05	0.000242	CcSEcCtD
Tamoxifen—Erythema multiforme—Topiramate—epilepsy syndrome	2.58e-05	0.000242	CcSEcCtD
Tamoxifen—Angioedema—Gabapentin—epilepsy syndrome	2.58e-05	0.000242	CcSEcCtD
Tamoxifen—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.58e-05	0.000242	CcSEcCtD
Tamoxifen—Vomiting—Felbamate—epilepsy syndrome	2.58e-05	0.000242	CcSEcCtD
Tamoxifen—Dry mouth—Pregabalin—epilepsy syndrome	2.57e-05	0.000241	CcSEcCtD
Tamoxifen—Pruritus—Carbamazepine—epilepsy syndrome	2.57e-05	0.00024	CcSEcCtD
Tamoxifen—Rash—Felbamate—epilepsy syndrome	2.56e-05	0.00024	CcSEcCtD
Tamoxifen—Dermatitis—Felbamate—epilepsy syndrome	2.55e-05	0.000239	CcSEcCtD
Tamoxifen—Headache—Felbamate—epilepsy syndrome	2.54e-05	0.000238	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.54e-05	0.000238	CcSEcCtD
Tamoxifen—Flushing—Topiramate—epilepsy syndrome	2.54e-05	0.000238	CcSEcCtD
Tamoxifen—Leukopenia—Gabapentin—epilepsy syndrome	2.53e-05	0.000237	CcSEcCtD
Tamoxifen—Dizziness—Clonazepam—epilepsy syndrome	2.53e-05	0.000237	CcSEcCtD
Tamoxifen—Nausea—Vigabatrin—epilepsy syndrome	2.53e-05	0.000237	CcSEcCtD
Tamoxifen—Vomiting—Zonisamide—epilepsy syndrome	2.52e-05	0.000237	CcSEcCtD
Tamoxifen—Insomnia—Valproic Acid—epilepsy syndrome	2.52e-05	0.000236	CcSEcCtD
Tamoxifen—Oedema—Pregabalin—epilepsy syndrome	2.52e-05	0.000236	CcSEcCtD
Tamoxifen—Asthenia—Lamotrigine—epilepsy syndrome	2.51e-05	0.000236	CcSEcCtD
Tamoxifen—Dizziness—Phenytoin—epilepsy syndrome	2.51e-05	0.000235	CcSEcCtD
Tamoxifen—Rash—Zonisamide—epilepsy syndrome	2.5e-05	0.000235	CcSEcCtD
Tamoxifen—Infection—Pregabalin—epilepsy syndrome	2.5e-05	0.000234	CcSEcCtD
Tamoxifen—Paraesthesia—Valproic Acid—epilepsy syndrome	2.5e-05	0.000234	CcSEcCtD
Tamoxifen—Dermatitis—Zonisamide—epilepsy syndrome	2.5e-05	0.000234	CcSEcCtD
Tamoxifen—Dizziness—Oxcarbazepine—epilepsy syndrome	2.5e-05	0.000234	CcSEcCtD
Tamoxifen—Promazine—ADRA2A—epilepsy syndrome	2.49e-05	0.00988	CrCbGaD
Tamoxifen—Nausea—Diazepam—epilepsy syndrome	2.49e-05	0.000233	CcSEcCtD
Tamoxifen—Headache—Zonisamide—epilepsy syndrome	2.49e-05	0.000233	CcSEcCtD
Tamoxifen—Dyspnoea—Valproic Acid—epilepsy syndrome	2.48e-05	0.000233	CcSEcCtD
Tamoxifen—Diarrhoea—Carbamazepine—epilepsy syndrome	2.48e-05	0.000233	CcSEcCtD
Tamoxifen—Pruritus—Lamotrigine—epilepsy syndrome	2.48e-05	0.000232	CcSEcCtD
Tamoxifen—Cough—Gabapentin—epilepsy syndrome	2.47e-05	0.000231	CcSEcCtD
Tamoxifen—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.46e-05	0.000231	CcSEcCtD
Tamoxifen—Dyspepsia—Valproic Acid—epilepsy syndrome	2.45e-05	0.00023	CcSEcCtD
Tamoxifen—Hypertension—Gabapentin—epilepsy syndrome	2.44e-05	0.000229	CcSEcCtD
Tamoxifen—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.43e-05	0.000228	CcSEcCtD
Tamoxifen—Vomiting—Clonazepam—epilepsy syndrome	2.43e-05	0.000228	CcSEcCtD
Tamoxifen—Decreased appetite—Valproic Acid—epilepsy syndrome	2.42e-05	0.000227	CcSEcCtD
Tamoxifen—Alopecia—Topiramate—epilepsy syndrome	2.42e-05	0.000226	CcSEcCtD
Tamoxifen—Vomiting—Phenytoin—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Rash—Clonazepam—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Dermatitis—Clonazepam—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Chest pain—Gabapentin—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Arthralgia—Gabapentin—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Myalgia—Gabapentin—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Nausea—Felbamate—epilepsy syndrome	2.41e-05	0.000226	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Vomiting—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Fatigue—Valproic Acid—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Anxiety—Gabapentin—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Anorexia—Pregabalin—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Dizziness—Carbamazepine—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Diarrhoea—Lamotrigine—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Headache—Clonazepam—epilepsy syndrome	2.4e-05	0.000225	CcSEcCtD
Tamoxifen—Rash—Phenytoin—epilepsy syndrome	2.39e-05	0.000225	CcSEcCtD
Tamoxifen—Dermatitis—Phenytoin—epilepsy syndrome	2.39e-05	0.000224	CcSEcCtD
Tamoxifen—Rash—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Pain—Valproic Acid—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Constipation—Valproic Acid—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Headache—Phenytoin—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Erythema—Topiramate—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Discomfort—Gabapentin—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Tamoxifen—Headache—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000222	CcSEcCtD
Tamoxifen—Nausea—Zonisamide—epilepsy syndrome	2.36e-05	0.000221	CcSEcCtD
Tamoxifen—Dry mouth—Gabapentin—epilepsy syndrome	2.35e-05	0.000221	CcSEcCtD
Tamoxifen—Clomifene—ABCB1—epilepsy syndrome	2.33e-05	0.00924	CrCbGaD
Tamoxifen—Dysgeusia—Topiramate—epilepsy syndrome	2.33e-05	0.000218	CcSEcCtD
Tamoxifen—Dizziness—Lamotrigine—epilepsy syndrome	2.32e-05	0.000217	CcSEcCtD
Tamoxifen—Oedema—Gabapentin—epilepsy syndrome	2.31e-05	0.000216	CcSEcCtD
Tamoxifen—Vomiting—Carbamazepine—epilepsy syndrome	2.31e-05	0.000216	CcSEcCtD
Tamoxifen—Back pain—Topiramate—epilepsy syndrome	2.3e-05	0.000216	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.29e-05	0.000215	CcSEcCtD
Tamoxifen—Infection—Gabapentin—epilepsy syndrome	2.29e-05	0.000215	CcSEcCtD
Tamoxifen—Muscle spasms—Topiramate—epilepsy syndrome	2.29e-05	0.000214	CcSEcCtD
Tamoxifen—Rash—Carbamazepine—epilepsy syndrome	2.29e-05	0.000214	CcSEcCtD
Tamoxifen—Dermatitis—Carbamazepine—epilepsy syndrome	2.28e-05	0.000214	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.28e-05	0.000213	CcSEcCtD
Tamoxifen—Insomnia—Pregabalin—epilepsy syndrome	2.28e-05	0.000213	CcSEcCtD
Tamoxifen—Nausea—Clonazepam—epilepsy syndrome	2.27e-05	0.000213	CcSEcCtD
Tamoxifen—Headache—Carbamazepine—epilepsy syndrome	2.27e-05	0.000213	CcSEcCtD
Tamoxifen—Paraesthesia—Pregabalin—epilepsy syndrome	2.26e-05	0.000212	CcSEcCtD
Tamoxifen—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.26e-05	0.000212	CcSEcCtD
Tamoxifen—Nausea—Phenytoin—epilepsy syndrome	2.26e-05	0.000212	CcSEcCtD
Tamoxifen—Dyspnoea—Pregabalin—epilepsy syndrome	2.24e-05	0.00021	CcSEcCtD
Tamoxifen—Nausea—Oxcarbazepine—epilepsy syndrome	2.24e-05	0.00021	CcSEcCtD
Tamoxifen—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.23e-05	0.000209	CcSEcCtD
Tamoxifen—Vomiting—Lamotrigine—epilepsy syndrome	2.23e-05	0.000209	CcSEcCtD
Tamoxifen—Urticaria—Valproic Acid—epilepsy syndrome	2.21e-05	0.000207	CcSEcCtD
Tamoxifen—Rash—Lamotrigine—epilepsy syndrome	2.21e-05	0.000207	CcSEcCtD
Tamoxifen—Dermatitis—Lamotrigine—epilepsy syndrome	2.21e-05	0.000207	CcSEcCtD
Tamoxifen—Dextropropoxyphene—CYP2D6—epilepsy syndrome	2.2e-05	0.00874	CrCbGaD
Tamoxifen—Abdominal pain—Valproic Acid—epilepsy syndrome	2.2e-05	0.000206	CcSEcCtD
Tamoxifen—Anorexia—Gabapentin—epilepsy syndrome	2.2e-05	0.000206	CcSEcCtD
Tamoxifen—Anaemia—Topiramate—epilepsy syndrome	2.2e-05	0.000206	CcSEcCtD
Tamoxifen—Headache—Lamotrigine—epilepsy syndrome	2.2e-05	0.000206	CcSEcCtD
Tamoxifen—Decreased appetite—Pregabalin—epilepsy syndrome	2.19e-05	0.000205	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.17e-05	0.000204	CcSEcCtD
Tamoxifen—Fatigue—Pregabalin—epilepsy syndrome	2.17e-05	0.000203	CcSEcCtD
Tamoxifen—Nausea—Carbamazepine—epilepsy syndrome	2.15e-05	0.000202	CcSEcCtD
Tamoxifen—Pain—Pregabalin—epilepsy syndrome	2.15e-05	0.000202	CcSEcCtD
Tamoxifen—Constipation—Pregabalin—epilepsy syndrome	2.15e-05	0.000202	CcSEcCtD
Tamoxifen—Leukopenia—Topiramate—epilepsy syndrome	2.13e-05	0.0002	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.1e-05	0.000197	CcSEcCtD
Tamoxifen—Loperamide—CYP2D6—epilepsy syndrome	2.1e-05	0.00833	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2C19—epilepsy syndrome	2.09e-05	0.00829	CrCbGaD
Tamoxifen—Insomnia—Gabapentin—epilepsy syndrome	2.09e-05	0.000196	CcSEcCtD
Tamoxifen—Nausea—Lamotrigine—epilepsy syndrome	2.08e-05	0.000195	CcSEcCtD
Tamoxifen—Cough—Topiramate—epilepsy syndrome	2.08e-05	0.000195	CcSEcCtD
Tamoxifen—Paraesthesia—Gabapentin—epilepsy syndrome	2.07e-05	0.000194	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.06e-05	0.000193	CcSEcCtD
Tamoxifen—Dyspnoea—Gabapentin—epilepsy syndrome	2.06e-05	0.000193	CcSEcCtD
Tamoxifen—Hypertension—Topiramate—epilepsy syndrome	2.05e-05	0.000193	CcSEcCtD
Tamoxifen—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.05e-05	0.000192	CcSEcCtD
Tamoxifen—Dyspepsia—Gabapentin—epilepsy syndrome	2.03e-05	0.00019	CcSEcCtD
Tamoxifen—Arthralgia—Topiramate—epilepsy syndrome	2.03e-05	0.00019	CcSEcCtD
Tamoxifen—Chest pain—Topiramate—epilepsy syndrome	2.03e-05	0.00019	CcSEcCtD
Tamoxifen—Myalgia—Topiramate—epilepsy syndrome	2.03e-05	0.00019	CcSEcCtD
Tamoxifen—Anxiety—Topiramate—epilepsy syndrome	2.02e-05	0.000189	CcSEcCtD
Tamoxifen—Methadone—CYP2C19—epilepsy syndrome	2.02e-05	0.008	CrCbGaD
Tamoxifen—Decreased appetite—Gabapentin—epilepsy syndrome	2.01e-05	0.000188	CcSEcCtD
Tamoxifen—Discomfort—Topiramate—epilepsy syndrome	2e-05	0.000188	CcSEcCtD
Tamoxifen—Urticaria—Pregabalin—epilepsy syndrome	2e-05	0.000187	CcSEcCtD
Tamoxifen—Asthenia—Valproic Acid—epilepsy syndrome	2e-05	0.000187	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.99e-05	0.000187	CcSEcCtD
Tamoxifen—Fatigue—Gabapentin—epilepsy syndrome	1.99e-05	0.000187	CcSEcCtD
Tamoxifen—Abdominal pain—Pregabalin—epilepsy syndrome	1.99e-05	0.000187	CcSEcCtD
Tamoxifen—Dry mouth—Topiramate—epilepsy syndrome	1.98e-05	0.000186	CcSEcCtD
Tamoxifen—Constipation—Gabapentin—epilepsy syndrome	1.97e-05	0.000185	CcSEcCtD
Tamoxifen—Pain—Gabapentin—epilepsy syndrome	1.97e-05	0.000185	CcSEcCtD
Tamoxifen—Pruritus—Valproic Acid—epilepsy syndrome	1.97e-05	0.000185	CcSEcCtD
Tamoxifen—Oedema—Topiramate—epilepsy syndrome	1.94e-05	0.000182	CcSEcCtD
Tamoxifen—Infection—Topiramate—epilepsy syndrome	1.93e-05	0.000181	CcSEcCtD
Tamoxifen—Diarrhoea—Valproic Acid—epilepsy syndrome	1.91e-05	0.000179	CcSEcCtD
Tamoxifen—Thrombocytopenia—Topiramate—epilepsy syndrome	1.9e-05	0.000178	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.89e-05	0.000177	CcSEcCtD
Tamoxifen—Hyperhidrosis—Topiramate—epilepsy syndrome	1.88e-05	0.000176	CcSEcCtD
Tamoxifen—Hypersensitivity—Pregabalin—epilepsy syndrome	1.85e-05	0.000174	CcSEcCtD
Tamoxifen—Anorexia—Topiramate—epilepsy syndrome	1.85e-05	0.000174	CcSEcCtD
Tamoxifen—Dizziness—Valproic Acid—epilepsy syndrome	1.84e-05	0.000173	CcSEcCtD
Tamoxifen—Urticaria—Gabapentin—epilepsy syndrome	1.83e-05	0.000172	CcSEcCtD
Tamoxifen—Abdominal pain—Gabapentin—epilepsy syndrome	1.82e-05	0.000171	CcSEcCtD
Tamoxifen—Asthenia—Pregabalin—epilepsy syndrome	1.81e-05	0.000169	CcSEcCtD
Tamoxifen—Promazine—CYP2C19—epilepsy syndrome	1.8e-05	0.00715	CrCbGaD
Tamoxifen—Pruritus—Pregabalin—epilepsy syndrome	1.78e-05	0.000167	CcSEcCtD
Tamoxifen—Vomiting—Valproic Acid—epilepsy syndrome	1.77e-05	0.000166	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.77e-05	0.000166	CcSEcCtD
Tamoxifen—Insomnia—Topiramate—epilepsy syndrome	1.76e-05	0.000165	CcSEcCtD
Tamoxifen—Rash—Valproic Acid—epilepsy syndrome	1.76e-05	0.000165	CcSEcCtD
Tamoxifen—Dermatitis—Valproic Acid—epilepsy syndrome	1.75e-05	0.000164	CcSEcCtD
Tamoxifen—Headache—Valproic Acid—epilepsy syndrome	1.74e-05	0.000164	CcSEcCtD
Tamoxifen—Paraesthesia—Topiramate—epilepsy syndrome	1.74e-05	0.000163	CcSEcCtD
Tamoxifen—Dyspnoea—Topiramate—epilepsy syndrome	1.73e-05	0.000162	CcSEcCtD
Tamoxifen—Diarrhoea—Pregabalin—epilepsy syndrome	1.72e-05	0.000161	CcSEcCtD
Tamoxifen—Dyspepsia—Topiramate—epilepsy syndrome	1.71e-05	0.00016	CcSEcCtD
Tamoxifen—Hypersensitivity—Gabapentin—epilepsy syndrome	1.7e-05	0.000159	CcSEcCtD
Tamoxifen—Decreased appetite—Topiramate—epilepsy syndrome	1.69e-05	0.000158	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.68e-05	0.000157	CcSEcCtD
Tamoxifen—Fatigue—Topiramate—epilepsy syndrome	1.67e-05	0.000157	CcSEcCtD
Tamoxifen—Dizziness—Pregabalin—epilepsy syndrome	1.66e-05	0.000156	CcSEcCtD
Tamoxifen—Pain—Topiramate—epilepsy syndrome	1.66e-05	0.000156	CcSEcCtD
Tamoxifen—Constipation—Topiramate—epilepsy syndrome	1.66e-05	0.000156	CcSEcCtD
Tamoxifen—Asthenia—Gabapentin—epilepsy syndrome	1.66e-05	0.000155	CcSEcCtD
Tamoxifen—Nausea—Valproic Acid—epilepsy syndrome	1.65e-05	0.000155	CcSEcCtD
Tamoxifen—Pruritus—Gabapentin—epilepsy syndrome	1.63e-05	0.000153	CcSEcCtD
Tamoxifen—Vomiting—Pregabalin—epilepsy syndrome	1.6e-05	0.00015	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.59e-05	0.000149	CcSEcCtD
Tamoxifen—Rash—Pregabalin—epilepsy syndrome	1.59e-05	0.000149	CcSEcCtD
Tamoxifen—Dermatitis—Pregabalin—epilepsy syndrome	1.59e-05	0.000149	CcSEcCtD
Tamoxifen—Diarrhoea—Gabapentin—epilepsy syndrome	1.58e-05	0.000148	CcSEcCtD
Tamoxifen—Headache—Pregabalin—epilepsy syndrome	1.58e-05	0.000148	CcSEcCtD
Tamoxifen—Diphenhydramine—CYP2D6—epilepsy syndrome	1.55e-05	0.00614	CrCbGaD
Tamoxifen—Urticaria—Topiramate—epilepsy syndrome	1.54e-05	0.000145	CcSEcCtD
Tamoxifen—Abdominal pain—Topiramate—epilepsy syndrome	1.54e-05	0.000144	CcSEcCtD
Tamoxifen—Dizziness—Gabapentin—epilepsy syndrome	1.53e-05	0.000143	CcSEcCtD
Tamoxifen—Loperamide—ABCB1—epilepsy syndrome	1.5e-05	0.00595	CrCbGaD
Tamoxifen—Methadone—CYP2D6—epilepsy syndrome	1.5e-05	0.00593	CrCbGaD
Tamoxifen—Nausea—Pregabalin—epilepsy syndrome	1.5e-05	0.00014	CcSEcCtD
Tamoxifen—Vomiting—Gabapentin—epilepsy syndrome	1.47e-05	0.000138	CcSEcCtD
Tamoxifen—Promazine—HTR2A—epilepsy syndrome	1.46e-05	0.00579	CrCbGaD
Tamoxifen—Rash—Gabapentin—epilepsy syndrome	1.46e-05	0.000136	CcSEcCtD
Tamoxifen—Dermatitis—Gabapentin—epilepsy syndrome	1.45e-05	0.000136	CcSEcCtD
Tamoxifen—Headache—Gabapentin—epilepsy syndrome	1.45e-05	0.000136	CcSEcCtD
Tamoxifen—Hypersensitivity—Topiramate—epilepsy syndrome	1.43e-05	0.000134	CcSEcCtD
Tamoxifen—Asthenia—Topiramate—epilepsy syndrome	1.39e-05	0.000131	CcSEcCtD
Tamoxifen—Pruritus—Topiramate—epilepsy syndrome	1.37e-05	0.000129	CcSEcCtD
Tamoxifen—Nausea—Gabapentin—epilepsy syndrome	1.37e-05	0.000129	CcSEcCtD
Tamoxifen—Diarrhoea—Topiramate—epilepsy syndrome	1.33e-05	0.000125	CcSEcCtD
Tamoxifen—Dizziness—Topiramate—epilepsy syndrome	1.28e-05	0.00012	CcSEcCtD
Tamoxifen—Vomiting—Topiramate—epilepsy syndrome	1.23e-05	0.000116	CcSEcCtD
Tamoxifen—Rash—Topiramate—epilepsy syndrome	1.22e-05	0.000115	CcSEcCtD
Tamoxifen—Dermatitis—Topiramate—epilepsy syndrome	1.22e-05	0.000115	CcSEcCtD
Tamoxifen—Headache—Topiramate—epilepsy syndrome	1.22e-05	0.000114	CcSEcCtD
Tamoxifen—Nausea—Topiramate—epilepsy syndrome	1.15e-05	0.000108	CcSEcCtD
Tamoxifen—Methadone—ABCB1—epilepsy syndrome	1.07e-05	0.00423	CrCbGaD
Tamoxifen—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.51e-06	2.75e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.5e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.5e-06	2.73e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.49e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.49e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.49e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.48e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TH—epilepsy syndrome	1.48e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.48e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.48e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.47e-06	2.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HES1—epilepsy syndrome	1.46e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.46e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.45e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—epilepsy syndrome	1.45e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.45e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.44e-06	2.64e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.43e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AGT—epilepsy syndrome	1.43e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.42e-06	2.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FYN—epilepsy syndrome	1.42e-06	2.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.42e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.42e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.42e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.41e-06	2.58e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.4e-06	2.56e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APOE—epilepsy syndrome	1.4e-06	2.56e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.4e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.39e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.39e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.39e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.38e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.38e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.38e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.37e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—POMC—epilepsy syndrome	1.37e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.37e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.36e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.36e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.36e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.36e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TH—epilepsy syndrome	1.36e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.36e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NGF—epilepsy syndrome	1.35e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.34e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.33e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—POMC—epilepsy syndrome	1.32e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.32e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	1.32e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.31e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.3e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.29e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.29e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.29e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.29e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.29e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.27e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.27e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.27e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.26e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.26e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.26e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—epilepsy syndrome	1.26e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.26e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ALB—epilepsy syndrome	1.25e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.24e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.24e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	1.22e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AGT—epilepsy syndrome	1.22e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.22e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.21e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TH—epilepsy syndrome	1.21e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ALB—epilepsy syndrome	1.21e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—POMC—epilepsy syndrome	1.2e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.2e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—epilepsy syndrome	1.2e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.19e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.19e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.19e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.19e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.19e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TH—epilepsy syndrome	1.18e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.18e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—epilepsy syndrome	1.18e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.18e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.18e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.17e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—epilepsy syndrome	1.17e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.17e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.17e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.17e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.15e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.15e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.13e-06	2.07e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.13e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.13e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.12e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.12e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.12e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.12e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TH—epilepsy syndrome	1.11e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.11e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TH—epilepsy syndrome	1.11e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.1e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—epilepsy syndrome	1.1e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.09e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.09e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.09e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.06e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.06e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.05e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—POMC—epilepsy syndrome	1.03e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.03e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.03e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.02e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.01e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.01e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	1.01e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.01e-06	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1e-06	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—epilepsy syndrome	1e-06	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAT—epilepsy syndrome	9.98e-07	1.82e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—epilepsy syndrome	9.96e-07	1.82e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—epilepsy syndrome	9.89e-07	1.81e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—epilepsy syndrome	9.87e-07	1.8e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAT—epilepsy syndrome	9.74e-07	1.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	9.71e-07	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AGT—epilepsy syndrome	9.67e-07	1.77e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—epilepsy syndrome	9.59e-07	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	9.58e-07	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	9.51e-07	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	9.48e-07	1.73e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—epilepsy syndrome	9.48e-07	1.73e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TH—epilepsy syndrome	9.45e-07	1.72e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	9.36e-07	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	9.31e-07	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.3e-07	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	9.22e-07	1.68e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAT—epilepsy syndrome	9.18e-07	1.68e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	9.12e-07	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAT—epilepsy syndrome	9.1e-07	1.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	9.09e-07	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	9.06e-07	1.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.03e-07	1.65e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	8.93e-07	1.63e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AGT—epilepsy syndrome	8.87e-07	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	8.85e-07	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—epilepsy syndrome	8.82e-07	1.61e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.81e-07	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	8.72e-07	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—epilepsy syndrome	8.69e-07	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—epilepsy syndrome	8.64e-07	1.58e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—epilepsy syndrome	8.62e-07	1.57e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RELA—epilepsy syndrome	8.44e-07	1.54e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—epilepsy syndrome	8.3e-07	1.52e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	8.27e-07	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—epilepsy syndrome	8.23e-07	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.18e-07	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—epilepsy syndrome	8.14e-07	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—epilepsy syndrome	8.04e-07	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AGT—epilepsy syndrome	7.92e-07	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	7.88e-07	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—epilepsy syndrome	7.87e-07	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—epilepsy syndrome	7.86e-07	1.43e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.79e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAT—epilepsy syndrome	7.78e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—epilepsy syndrome	7.76e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.75e-07	1.41e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AGT—epilepsy syndrome	7.73e-07	1.41e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	7.61e-07	1.39e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—epilepsy syndrome	7.57e-07	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.57e-07	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—epilepsy syndrome	7.46e-07	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—epilepsy syndrome	7.42e-07	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	7.4e-07	1.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—epilepsy syndrome	7.39e-07	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	7.32e-07	1.34e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—epilepsy syndrome	7.29e-07	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TH—epilepsy syndrome	7.29e-07	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AGT—epilepsy syndrome	7.28e-07	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AGT—epilepsy syndrome	7.22e-07	1.32e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	7.19e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.13e-07	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—epilepsy syndrome	7.07e-07	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.03e-07	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	7.03e-07	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	6.89e-07	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.87e-07	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—epilepsy syndrome	6.81e-07	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—epilepsy syndrome	6.66e-07	1.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—epilepsy syndrome	6.63e-07	1.21e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—epilepsy syndrome	6.5e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	6.49e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	6.46e-07	1.18e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—epilepsy syndrome	6.34e-07	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.17e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.13e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.08e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.08e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.07e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.04e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAT—epilepsy syndrome	6e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	5.95e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—epilepsy syndrome	5.93e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.84e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.59e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—epilepsy syndrome	5.54e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—epilepsy syndrome	5.5e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.43e-07	9.91e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.31e-07	9.7e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—epilepsy syndrome	5.3e-07	9.67e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.19e-07	9.48e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—epilepsy syndrome	5.19e-07	9.47e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.89e-07	8.92e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4.85e-07	8.84e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—epilepsy syndrome	4.82e-07	8.8e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—epilepsy syndrome	4.78e-07	8.72e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.76e-07	8.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.73e-07	8.64e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.66e-07	8.51e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.38e-07	8e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.14e-07	7.56e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	4.12e-07	7.52e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.01e-07	7.31e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.65e-07	6.67e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—epilepsy syndrome	3.53e-07	6.45e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—epilepsy syndrome	3.46e-07	6.32e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.45e-07	6.31e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—epilepsy syndrome	3.26e-07	5.96e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.2e-07	5.83e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—epilepsy syndrome	2.99e-07	5.46e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.67e-07	4.87e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.61e-07	4.76e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.46e-07	4.48e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.44e-07	4.44e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.08e-07	3.8e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.61e-07	2.93e-06	CbGpPWpGaD
